Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04267562 · ClinicalTrials.gov registry record · NA

Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness

A NA study of Menorrhagia and Heavy Menstrual Bleeding, sponsored by MicroCube.

Completed
Registry status
NA
Development phase
219
Enrollment target
5
Study locations

NCT04267562 is a NA study of Menorrhagia and Heavy Menstrual Bleeding that has completed, run by MicroCube. The registered enrollment target is 219 participants, roughly in line with the 207-participant average among 10 other Menorrhagia trials with a reported enrollment target. The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04267562, a NA study of Menorrhagia and Heavy Menstrual Bleeding, has completed, sponsored by MicroCube.

COMPLETED
Registry status
NA
Development phase
219 participants
Enrollment target
5
Study locations

Study Summary

The EASE Clinical Trial is prospective, multi-center, single-arm (open-label), non-randomized, clinical trial to evaluate the Minitouch Endometrial Ablation System ("Minitouch System") in premenopausal women with menorrhagia.

Interventions

  • DEVICE Minitouch System

Study Locations (5)

Texas

  • Women's Health Texas (Women Partners in Health) - Austin
  • AA ObGyn - Austin
  • OBGYN North - Austin

Indiana

  • CMB Research - Newburgh

Ohio

  • Amy Brenner, MD & Associates - Mason

Trial Details

FieldValue
Enrollment Target 219 participants
Start Date 2020-02-28
Est. Completion 2023-12-31
Phase NA

Sponsor

MicroCube

1 total trials

What the Registry Record Tells You About NCT04267562

The ClinicalTrials.gov registry entry for NCT04267562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 207-participant average among 10 other Menorrhagia trials with a reported enrollment target. The listed sponsor is MicroCube, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Menorrhagia appearing as the primary indexed condition, and to 1 intervention - of which Minitouch System is the first listed.

NCT04267562 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Texas, Indiana, Ohio.

Frequently Asked Questions

What is clinical trial NCT04267562 about?

NCT04267562 is a clinical study titled "Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness". The EASE Clinical Trial is prospective, multi-center, single-arm (open-label), non-randomized, clinical trial to evaluate the Minitouch Endometrial Ablation System ("Minitouch System") in premenopausal women with menorrhagia.

What is the current status of trial NCT04267562?

This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2020-02-28. Estimated completion is 2023-12-31.

What conditions does trial NCT04267562 study?

This clinical trial studies the following conditions: Menorrhagia, Heavy Menstrual Bleeding, Heavy Uterine Bleeding.

What interventions are being tested in trial NCT04267562?

The interventions under investigation include: Minitouch System (DEVICE).

Who is sponsoring clinical trial NCT04267562?

This trial is sponsored by MicroCube, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04267562 being conducted?

This trial has 5 study locations across Indiana, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menorrhagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.